首页> 美国卫生研究院文献>Filaria Journal >Laboratory and field studies to investigate the efficacy of a novel orally administered combination product containing moxidectin sarolaner and pyrantel for the prevention of heartworm disease (Dirofilaria immitis) in dogs
【2h】

Laboratory and field studies to investigate the efficacy of a novel orally administered combination product containing moxidectin sarolaner and pyrantel for the prevention of heartworm disease (Dirofilaria immitis) in dogs

机译:实验室和野外研究旨在研究口服含莫昔克丁沙拉那钠和吡喃酮的新型组合产品预防犬心丝虫病(Dirofilaria炎)的功效

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundDirofilaria immitis is a filarial parasite of dogs that can cause serious or fatal cardiopulmonary disease. Three studies were conducted to evaluate the efficacy and safety of monthly treatment with moxidectin in a chewable tablet product in combination with sarolaner and pyrantel to prevent heartworm disease in dogs after experimental challenge and in a clinical field study in the USA.
机译:背景Dirofilaria炎是犬的丝虫病,可引起严重或致命的心肺疾病。在美国进行的一项临床实地研究中,进行了三项研究,以评估莫昔克丁每月咀嚼片产品与sarolaner和pyrantel联合使用可预防狗中的丝虫病的功效和安全性,以预防狗中的丝虫病。

著录项

相似文献

  • 外文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号